synthetic peptide comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-12-25. Numbers and descriptions here follow the published literature rather than marketing material.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
| Property | Value | Notes |
|---|---|---|
| Common name | AOD-9604 | Development code used in scientific literature. |
| Chemical class | Synthetic peptide | Fragment of human growth hormone. |
| Amino acid length | 16 residues | Matches hGH region 176-191. |
| Appearance | White to off-white powder | Typical lyophilized peptide solid. |
| Solubility | Soluble in water | Dissolves in aqueous media; exact behavior depends on salt form. |
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
== History == Insulin was discovered by Sir Frederick G Banting, Charles H Best, and JJR Macleod from the University of Toronto in 1921 as an injectable agent. German researchers first introduced the idea of inhalable insulin in 1924. Years of failure followed until scientists realized they might be able to use new technologies to turn insulin into a concentrated powder with particles sized for inhalation. In the 1980s Nektar Therapeutics, based on work by A. Carl Leopold on vitrifying proteins, developed technology to make insulin into small particles, technology then licensed to Pfizer. Alkermes developed a delivery device that they licensed to Eli Lilly and Company. Once concrete methods were developed, human tests began in the late 1990s. In January 2006, the U.S. Food and Drug Administration (FDA) approved the use of Exubera, a form of inhalable insulin developed by Pfizer. It was approved in the UK in August 2006 but reimbursed by the National Health Service only for people who had problems with needles. It was not reimbursed by any U.S. insurer. A 2007 systematic review concluded that the inhaled hexameric insulin (Exubera) "appears to be as effective, but no better than injected short-acting insulin. The additional cost is so much more that it is unlikely to be cost-effective." In 2007, Pfizer announced that it would no longer manufacture or market Exubera. According to Chairman and CEO Jeffrey Kindler this was because Exubera "failed to gain acceptance among patients and physicians".
Lys arylation Similar to cysteine, lysine N-arylation could be achieved through Pd OACs with different dialkylbiaryl phosphine ligands. Due to weaker nucleophilicity and slower reductive elimination rate compared to cysteine, the selection of supporting ligands is shown to be critical. The bulky BrettPhos and t-BuBrettPhos ligands in conjunction with mildly basic sodium phenoxide have been used as the strategy to functionalize lysines on peptide substrates. The reaction happens in mild conditions and is selective over most other nucleophilic amino acid residues.
There are also intra-country zones such as the Cactus Curtain surrounding the Guantanamo Bay Naval Base in Cuba, the Korean Demilitarised Zone along the North Korea-South Korea demarcation line and the Frontier Closed Area in Hong Kong. Important historical examples are the Wire of Death set up by the German Empire to control the Belgium–Netherlands border and the Iron Curtain, a set of border zones maintained by the Soviet Union and its satellite states along their borders with Western states. One of the most militarised parts was the restricted zone of the inner German border. While the zone was initially and officially for border security, it was eventually engineered to prevent escape from the Soviet sphere into the West. Ultimately, the Eastern Bloc governments resorted to using lethal countermeasures against those trying to cross the border, such as mined fences and orders to shoot anyone trying to cross into the West. The restrictions on building and habitation made the area a "green corridor", which today is known as the European Green Belt. In the area stretching inwards from its internal border with the mainland, Hong Kong maintains a Frontier Closed Area out of bounds to those without special authorisation. The area was established in the 1950s, when Hong Kong was under British administration, as a result of the Convention for the Extension of Hong Kong Territory before the transfer of sovereignty over Hong Kong in 1997. The area's purpose was to prevent illegal immigration and smuggling; smuggling had become prevalent as a consequence of the Korean War.
=== Daniel Van Deventer === Daniel Van Deventer (Alex Akpobome), nicknamed “DVD,” is a Pierpoint trader transferred from New York to London during plans to consolidate the two offices. A former protégé of Eric Tao, DVD’s rapid rise places him in direct competition with Eric, ultimately contributing to Eric’s demotion after the loss of Felim Bichan as a client. DVD assumes Eric’s responsibilities as CPS MD and begins a sexual relationship with Harper, encouraging her to consider relocating to New York as the London office faces closure. He later suspends Harper after secretly listening in on a call in which she helps Jesse Bloom unload positions at Pierpoint’s expense. DVD grows disillusioned with Pierpoint after being instructed by Adler to ignore Nicole Craig’s sexual assault of Venetia Berens, and sympathizes with Harper upon learning she was also assaulted by Nicole. He agrees to leave the firm with Harper, Eric, and Rishi, but is ultimately betrayed when Harper and Eric strike a deal with Adler to preserve a reduced London operation by branding DVD and Rishi as disloyal. DVD is fired along with much of the London office, discovering his dismissal only when his security badge stops working.
Sources: en.wikipedia.org
Researchers have been unable to exceed this average read size; like chain-termination sequencing alone, MS-based DNA sequencing may not be suitable for large de novo sequencing projects. Even so, a 2010 study did use the short sequence reads and mass spectroscopy to compare single-nucleotide polymorphisms in pathogenic Streptococcus strains.
East Tennesseans felt the state had squandered the proceeds from the sale of land in the Hiwassee District (1819) on a failed state bank, rather than on badly needed internal improvements. It wasn't until 1828 that a steamboat, the Atlas, managed to navigate Muscle Shoals and make it upriver to Knoxville. River improvements in the 1830s allowed Knoxville semi-annual access to the Mississippi, though by this time the city's merchants had shifted their focus to railroad construction.
== Current application of LED light therapy == Red light therapy, utilising red LED lights, originated from techniques intended to enhance plant growth in space and aid in astronauts' wound healing. Primarily used in dermatology, it enhances skin conditions by stimulating mitochondria, thereby increasing collagen production and blood circulation while reducing inflammation. Additionally, it plays a crucial role in photodynamic therapy, where it combines with photosensitive drugs to target and destroy cancerous cells through a light-induced chemical reaction. Blue light therapy is also a common LED light therapy to treat acne, skin cancer, and depression. While blue light therapy has similar mechanisms for skin enhancement as red light therapy, its usage for photodynamic therapies in treating cancer are slightly different. Blue light therapy stimulates immune system defences, destroys blood vessels that help cancer cells grow, and causes cell death by reacting with oxygen. It also prevents skin cancer and metastasis by removing precancerous and cancerous skin lesions. Application of red and blue LED light for photodynamic treatments are generally safe and can be used to treat different cancers. However, they may differ in the efficiency and response. For instance, In the treatment of Gorlin syndrome, a genetic disorder predisposed to cancer, studies have shown that blue light therapy achieves a higher tumor clearance rate and induces less pain than red light therapy.
Sources: en.wikipedia.org
Upon the development of microfluidic technology, coupling it with affinity chromatography meant modifying channel surfaces, packing coated beads, or packing with coated porous material, neither of which allow for replenishing the columns. This produces limitations that prevent the packing material from being changed or the column being regenerated. The approach they took to address those challenges meant incorporating TRP particles as a reversibly immobilized stationary phase. What separates this development from other AC methods is that the beads on which the modified TRP are attached can reversibly adhere to the inner surfaces of the microfluidic channels. The formulation of the smart bead matrix is a little complex, but in general PNIPAAm is modified two times, first with NHS, then with polyethylene glycol-biotin (PEG-b) resulting in PEG-b/pNIPAAm beads. The inner surface of the microfluidic channels is composed of polyethylene terephthalate, to which the PEG-b/pNIPAAm beads reversibly bind above the LCST. When the sample solution is passed through the channels, the target analyte binds to the biotin ligand. The temperature can then be brought below the LCST to dissociate and become removed from the inner channels. This allows for a system adept to being reloaded with stationary phase under mild conditions. They successfully separated and eluted Streptavidin. Further application of these procedures allow for portable AC columns which can be packed on site and used for local or clinical analytical separations of complex biological fluids.
Nicolás Maduro has been criticized for authoritarian rule since Hugo Chávez hand-picked him as the next president of Venezuela in 2013. According to Reuters, "Maduro ruled Venezuela with a heavy hand ... presiding over deep economic and social crises and resisting pressure from domestic opponents and foreign governments for political change", and was "long accused by critics both at home and abroad of being a dictator who jailed or persecuted political opponents and repeatedly staged sham elections". Mark Weisbrot states that Venezuela has faced an economic crisis since the oil glut of the 2010s, due to its export-dependent economy. For years, the US government pressured Maduro, considering him an "illegitimate leader". Unilateral US sanctions on Venezuela began in the 2010s, and escalated through 2025. According to a 2019 report by Mark Weisbrot and Jeffrey Sachs, sanctions caused Venezuela a loss of $38 billion between 2016 and 2019, prevented the government from resolving the crisis using fiscal and monetary policy changes, and in combination with preexisting negative trends resulted in an estimated 40,000 excess deaths between 2017 and 2018. The report's methodology and conclusions were criticized by other economists. Maduro's victory in the 2018 Venezuelan presidential election was disputed and 45 countries did not accept the results, causing a presidential crisis that divided the international community from 2019 to 2023. In May 2020, Venezuelan dissidents backed by Silvercorp USA attempted to infiltrate Venezuela by sea and overthrow Maduro in Operation Gideon.
Cesium atoms was subsequently used to show that single atoms of an element could be counted if its resonance ionization was performed in a counter in which an electron could be detected for an atom in its ground state. Subsequently, advanced techniques categorized under resonance ionization mass spectrometry (RIMS) were used to generate the relative abundance of various ion types by coupling the RIS lasers to magnetic sector, quadrupole, or time-of-flight (TOF) mass spectrometers. The field of resonance ionization spectroscopy (RIS) has largely been shaped by the formal and informal communications heralding its discovery. Research papers on RIS have heavily relied on self-citation from inception, a trend which climaxed three years later with the founding of a company to commercialize the technique.
=== Second half of 20th century === Several operational breakthroughs reshaped wholesaling and distribution globally. Large-scale distributors regained more control over distribution in many categories.:
Sources: en.wikipedia.org
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.
No. It contains only a small portion of the human growth hormone sequence. The full hormone has 191 amino acids and many additional actions that the fragment does not share.
The name refers to the amino acid positions in the human growth hormone chain. The fragment spans residues 176 through 191 at the C-terminal end. This naming convention helps distinguish it from full-length hGH.
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.